NasdaqGM:ATRCMedical Equipment
AtriCure (ATRC) Q1 Breakeven EPS Tests Bullish Profitability Narrative
For Q1 2026, AtriCure (ATRC) reported total revenue of US$141.2 million and basic EPS of about US$0.00, with net income excluding extra items at US$0.1 million. The trailing 12 months show revenue of US$552.2 million and a net loss of US$4.6 million with basic EPS of a US$0.10 loss. Over recent quarters, the company has seen revenue move from US$123.6 million in Q1 2025 to US$141.2 million in Q1 2026, while basic EPS has ranged from a loss of US$0.14 in Q1 2025 to about breakeven in the...